Session Idle:  seconds.

General Search of Food Request Database. IR-4 Food Use Request.
This page includes all the trials related to the PR#.
      

Submit Supporting/Similar Request
PR#PriorityPesticide(MFG)Commodity (Crop Group)Project Status
13493 + FLUXAPYROXAD + PYRACLOSTROBIN ( BASF ) ASPARAGUS (FERN) ( 22A = STALK AND STEM VEGETABLE SUBGROUP ) E/CS DATA ON-GOING

Reduced Risk Status:
IPM Compatibility: PER REQUESTER: VERY GOOD FIT; THIS PRODUCT PROVIDES A NEW FRAC CODE AND PROVIDES EFFECTIVE, LONG-LASTING PROTECTION:08/22
Reasons for need: STEMPHYLIUM VESICARIUM; CURRENTLY REGISTERED PRODUCTS INCLUDE PROTECTANTS AND STROBILURINS. NEW, MORE EFFECTIVE ACTIVES ARE NEEDED;
Requesting State(s): MI:Hausbeck, M* ;
PCR Use Pattern: MERIVON SC; DOSAGE-11 FL OZ/A; FOLIAR APPLICATION, 5 APPLICATIONS, RTI 14 DAYS, PHI 7 MONTHS
EPA Default Residue Trials: 2 5-2 10-3 11-2
IR-4 Residue Trial Plan:
Residue Protocol Use Pattern:
Efficacy/Crop Safety (E/CS) Data Required:
E/CS Research Comments: PR# 13489 (MIRAVIS PRIME [PYDIFLUMETOFEN + FLUDIOXONIL]) E/CS WORK IS COVERED UNDER THIS PROJECT; PER 2023 PERFORMANCE PROTOCOL: TESTING MERIVON XEMIUM (FLUXAPYROXAD 21.26% + PYRACLOSTROBIN 21.26%) AND MIRAVIS PRIME (PYDIFLUMETOFEN 12.8% + FLUDIOXONIL 21.4%) FOR PURPLE SPOT CONTROL ON ASPARAGUS FERNS; MAKE 3 FOLIAR APPLIC OF MERIVON XEMIUM TREATMENTS (2 RATES, WITH/WITHOUT NIS, 7-DAY INTERVAL) VS 2 APPLIC OF MIRAVIS PRIME + NIS (14-DAY INTERVAL), ALL IN 20-60 GPA; COMPARE VS A CHLOROTHALONIL STANDARD; BEGIN SPRAYS WHEN WEATHER IS FAVORABLE FOR INFECTION OR AT FIRST SIGNS OF DISEASE; EVALUATE EFFICACY AND CROP SAFETY; SEE PROTOCOL FOR MUCH MORE TREATMENT DETAIL;
Label Use Pattern Submitted To EPA:
EPA PIF Status: YELLOW 08/23
EPA Status:
EPA PRIA Date:
MRID:
Comments: ORIGINALLY, POTENTIAL: E/CS DATA BEFORE APPROVAL FOR RESIDUE, CHANGED TO E/CS DATA ONGOING: 03/23, JPB; THE PERFORMANCE PROTOCOL FOR THIS PR# IS ASSOCIATED WITH PR# 13489 RESULTS FROM TEH PROTOCOL WILL BE POSTED TO BOTH PR#'S: 03/23, JPB; YELLOW 08/23; Two Performance trials completed 2023, awaiting decisions for moving forward with Residue studies from MFG.: 01/24, JPB;
International Status:
Archive Location:
QA Archive:

               View International Status                View protocol            PST(Priority Setting Comments)  


View Performance/Crop Safety Data

Field Research DirectorExpediteTrial DelayField ID#RFCTO QAHQ RECD.Lab ID#Lab RECDLab CompProc. IDProc. ShippedProc. ReportRaw DataS Dir./Auditor
Hausbeck, Dr. Mary K. P 21-MI-DMP RECD -NONE PATEL
Hausbeck, Dr. Mary K. P 21-MI-DMP RECD -NONE PATEL
Hausbeck, Dr. Mary K. P 23-MIP04 RECD -NONE PATEL
Hausbeck, Dr. Mary K. P 23-MIP13 RECD -NONE PATEL
  IR-4 Help Desk: Phone number: 919-515-1552 Email: ir-4_project@ncsu.edu
Contact Us   IR-4 Advisories/Training    Events    Links    Upload Files